Dn B Asset Management As Sarepta Therapeutics, Inc. Transaction History
Dn B Asset Management As
- $19.9 Billion
- Q2 2024
A detailed history of Dn B Asset Management As transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 5,194 shares of SRPT stock, worth $669,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,194
Previous 5,541
6.26%
Holding current value
$669,610
Previous $717,000
14.37%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SRPT
# of Institutions
560Shares Held
85.5MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.33 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.16 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$557 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$534 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$492 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.3B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...